RecruitingPhase 2NCT05055635

Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)

ReRad III. Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy


Sponsor

University of Aarhus

Enrollment

55 participants

Start Date

Jul 7, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This protocol aims to determine toxicity and efficacy of re-irradiation for patients with recurrences from anal cancers with dose-escalated pencil beam proton therapy either pre-operative for marginally resectable recurrences or as a definitive treatment strategy (un-resectable, operation declined etc.). The over-all aim is to improve local tumor control with acceptable side effects.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests proton therapy — an advanced and more precise type of radiation treatment — for people with anal cancer that has come back after having already received radiation therapy. Because these patients can't safely receive conventional re-irradiation, proton therapy offers a way to deliver radiation again with less damage to surrounding healthy tissue. **You may be eligible if...** - You are 18 or older with confirmed recurrent squamous cell carcinoma of the anus - You have previously received radiation (more than 30 Gy) and a dose plan from the first treatment is available - Your case has been reviewed by a specialist team (MDT conference) - You are in reasonable health (performance status 0–2) with adequate organ function **You may NOT be eligible if...** - Your cancer has spread to distant organs without any curative treatment options - You are unable to have MRI or PET-CT scans - You cannot complete the full course of radiation and follow-up appointments Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONPencil beam proton therapy

Neo-adjuvant or definitive pencil beam proton therapy: 55 Gy(RBE)/44fx - 65 Gy(RBE)/52 fx (1.25 Gy per fraction), two fractions a day


Locations(1)

Danish Centre for Particle Therapy

Aarhus N, Aarhus, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05055635


Related Trials